Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Abertay University | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This pilot study aims to investigate whether 6 weeks of twice weekly High-intensity Interval Training (HIT) results in improvements in disease-specific measures, feelings of general well-being, physical fitness and cognitive function in patients with non-alcoholic fatty liver disease or non-alcoholic steatohepatitis.
The study aims to recruit up to 12 patients diagnosed with non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) from the liver clinics at Ninewells Hospital, Dundee. Suitable patients who give informed consent will be assessed at baseline, again after 6 weeks of no intervention to act as a control period, and thirdly after 6 weeks of twice-weekly high-intensity interval training (HIT).
Assessments will be performed with the patient fasted overnight, and will involve body composition measurements, blood pressure, a venous blood sample for circulating triglycerides, fasting glucose, insulin, liver enzymes alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and platelets. An oral glucose tolerance test will be performed using fingerprick capillary samples. Cognitive function tests for episodic memory, executive function and semantic memory will be performed and a questionnaire (SF-36) will be used to assess general well-being. Physical fitness will be assessed through a 12-minute walk test on a treadmill, which will allow estimation of maximal oxygen uptake capacity (VO2 max), and a "get up and go" test will be used to assess physical function.
The exercise intervention will involve a 2 minute warm-up, cycling at 50 rpm before the participants will be asked to cycle at 100rpm and a weight will be added (7% body weight for men and 6% body weight for women) as resistance. The sprint will last 6 seconds and the participant will be asked to rest for at least 1 minute. This will be repeated for a total of 5 sprints in sessions 1-3, 6 sprints in session 4, 7 sprints in sessions 5&6, 8 sprints in sessions 7&8, 9 sprints in sessions 9&10 and 10 sprints in sessions 11&12. Exercise heart rate will be monitored and recorded.
At least 3 days after the last HIT session the pre-intervention testing assessment will be repeated for a third time.
Changes in measured variables will be analysed via repeated measures analysis of variance (ANOVA) with post-hoc testing of all variables.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| High-intensity Interval Training (HIT) | Experimental | 6 week control period with no intervention then 6 weeks of twice weekly HIT |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| High-intensity Interval Training | Other | 2 minute warm-up at 50rpm, then increase to 100rpm. Weight added to bike (7% body weight for men 6% body weight for women). Continue effort for 6 seconds, then passive rest for at least 1 minute. Total 5 sprints in sessions 1-3, 6 sprints in session4, 7 sprints in sessions 5&6, 8 sprints in sessions 7&8, 9 sprints in sessions 9&10 and 10 sprints in sessions 11&12. |
| Measure | Description | Time Frame |
|---|---|---|
| Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) | calculation of insulin resistance via formula: fasting insulin (mIU/L) x fasting glucose (mg/dL)/405 normal insulin resistance -HOMA score <3 moderate insulin resistance -HOMA score 3-5 severe insulin resistance -HOMA score >5 Assessed at baseline, after 6 week control period and within 1 week of completing 6 weeks HIT | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
| Oral Glucose Tolerance Test | measurement of capillary samples for glucose at time 0, followed by every 20 minutes for 2 hours following ingestion of 75g glucose. Results graphed against time, then area under the curve calculated for each of the 3 assessments. | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
| AST: ALT Ratio | ratio of liver enzymes aspartate aminotransferase (AST) to alanine aminotransferase (ALT). used as a diagnostic aid e.g. AST:ALT of more than 2:1 is characteristic of alcoholic liver disease whereas fatty steatosis and many other causes of liver disease, ratio is less than or equal to 1. Ratio may rise as fibrosis and cirrhosis develop in viral hepatitis. | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
| FIB-4 | calculated from AST, ALT, platelets and participant's age and used to estimate amount of fibrosis in liver. Fib-4 score of <1.45 has negative predictive value of 90% for advanced fibrosis. | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
| Body Fat Mass Estimated Via Bioimpedance | total body fat and trunk fat estimated via bioimpedance measured after overnight fast, expressed as percentage | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Niels BJ Vollaard, PhD | University of Bath | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Abertay University | Dundee | DD1 1HG | United Kingdom | |||
| Ninewells Hospital |
There is no reason to share the IPD.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | High-intensity Interval Training (HIT) | 6 week control period with no intervention then 6 weeks of twice weekly HIT High-intensity Interval Training: 2 minute warm-up at 50rpm, then increase to 100rpm. Weight added to bike (7% body weight for men 6% body weight for women). Continue effort for 6 seconds, then passive rest for at least 1 minute. Total 5 sprints in sessions 1-3, 6 sprints in session4, 7 sprints in sessions 5&6, 8 sprints in sessions 7&8, 9 sprints in sessions 9&10 and 10 sprints in sessions 11&12. |
| Title | Milestones | Reasons Not Completed | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | High-intensity Interval Training (HIT) | 6 week control period with no intervention then 6 weeks of twice weekly HIT High-intensity Interval Training: 2 minute warm-up at 50rpm, then increase to 100rpm. Weight added to bike (7% body weight for men 6% body weight for women). Continue effort for 6 seconds, then passive rest for at least 1 minute. Total 5 sprints in sessions 1-3, 6 sprints in session4, 7 sprints in sessions 5&6, 8 sprints in sessions 7&8, 9 sprints in sessions 9&10 and 10 sprints in sessions 11&12. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) | calculation of insulin resistance via formula: fasting insulin (mIU/L) x fasting glucose (mg/dL)/405 normal insulin resistance -HOMA score <3 moderate insulin resistance -HOMA score 3-5 severe insulin resistance -HOMA score >5 Assessed at baseline, after 6 week control period and within 1 week of completing 6 weeks HIT | Posted | Mean | Standard Deviation | units on a scale | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
|
Not provided
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | High-intensity Interval Training (HIT) | 6 week control period with no intervention then 6 weeks of twice weekly HIT High-intensity Interval Training: 2 minute warm-up at 50rpm, then increase to 100rpm. Weight added to bike (7% body weight for men 6% body weight for women). Continue effort for 6 seconds, then passive rest for at least 1 minute. Total 5 sprints in sessions 1-3, 6 sprints in session4, 7 sprints in sessions 5&6, 8 sprints in sessions 7&8, 9 sprints in sessions 9&10 and 10 sprints in sessions 11&12. |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Myocardial Infarction | Cardiac disorders | Non-systematic Assessment | occurred at home during 6 week period of HIT intervention. Cardiologist concluded HIT had not contributed to his infarction |
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr Niels Vollaard | University of Striling | +441786466488 | n.vollaard@stir.ac.uk |
Not provided
| ID | Term |
|---|---|
| D065626 | Non-alcoholic Fatty Liver Disease |
| ID | Term |
|---|---|
| D005234 | Fatty Liver |
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000072696 | High-Intensity Interval Training |
| D015444 | Exercise |
| ID | Term |
|---|---|
| D064797 | Physical Conditioning, Human |
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
No Masking, this was not possible with this study design.
Not provided
|
|
| Blood Pressure | taken with participant supine, measured on left arm | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
| General Well-being as Assessed by SF-36 Questionnaire | Assessment of: physical functioning, social functioning, mental health, pain, change in health, physical role limitation, mental role limitation, energy and vitality, health perception over preceding 4 weeks (other than change in health, which is a comparison to health the preceding year), expressed as a transformed score range 0-100, with a higher score indicating better function/freedom from pain etc | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
| Short-term Memory Recall | testing of verbal word presentation-immediate recall of 10 words (60 seconds for recall) Maximum =10, minimum =0 | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
| Estimated VO2 Max | VO2 max estimated via submaximal exercise test-submaximal treadmill walking test Calculated via formula: VO2max= 15.1+21.8 x speed (miles per hour) - 0.327 x heart rate (beats per minute) - 0.263 x speed x age (years) + 0.00504 x heart rate x age + 5.98 x gender (0=female, 1=male) | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
| Physical Function-"Get up and go" Test | participant will be timed standing up from chair unaided,walking 30m, turning round and returning to a seated position on the chair, the average time of 3 attempts will be recorded. | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
| Ankle Brachial Pressure Index (ABPI) | ratio of blood pressure in left arm and right ankle | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
| Long-term Memory Recall | testing of verbal word presentation-delayed recall of 10 words 10 minutes after words initially presented (within 60 seconds). Maximum= 10 words, minimum = no words | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
| Executive Function (Verbal Fluency Test) | written verbal fluency test: participant asked to write down as many English words as possible within 60 seconds, starting with a particular letter of the alphabet, excluding proper nouns or plurals. Baseline assessment-letter A Post Control assessment -letter S After HIT assessment -letter F | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
| Dundee |
| DD1 9SY |
| United Kingdom |
| Participants |
|
| Age, Continuous | Mean | Standard Deviation | years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| height | Mean | Standard Deviation | metres |
|
| body mass index (BMI) | Mean | Standard Deviation | kg/m^2 |
|
| diagnosis | Number | participants |
|
| OG002 | After HIT Assessment | final assessment within 1 week of completing 6 weeks of HIT |
|
|
|
| Primary | Oral Glucose Tolerance Test | measurement of capillary samples for glucose at time 0, followed by every 20 minutes for 2 hours following ingestion of 75g glucose. Results graphed against time, then area under the curve calculated for each of the 3 assessments. | Posted | Mean | Standard Deviation | mmol/L*min | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
|
|
|
|
| Primary | AST: ALT Ratio | ratio of liver enzymes aspartate aminotransferase (AST) to alanine aminotransferase (ALT). used as a diagnostic aid e.g. AST:ALT of more than 2:1 is characteristic of alcoholic liver disease whereas fatty steatosis and many other causes of liver disease, ratio is less than or equal to 1. Ratio may rise as fibrosis and cirrhosis develop in viral hepatitis. | Posted | Mean | Standard Deviation | ratio | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
|
|
|
|
| Primary | FIB-4 | calculated from AST, ALT, platelets and participant's age and used to estimate amount of fibrosis in liver. Fib-4 score of <1.45 has negative predictive value of 90% for advanced fibrosis. | Posted | Mean | Standard Deviation | Fibrosis Score | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
|
|
|
|
| Primary | Body Fat Mass Estimated Via Bioimpedance | total body fat and trunk fat estimated via bioimpedance measured after overnight fast, expressed as percentage | Posted | Mean | Standard Deviation | percentage body fat | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
|
|
|
|
| Primary | Blood Pressure | taken with participant supine, measured on left arm | Posted | Mean | Standard Deviation | mmHg | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
|
|
|
|
| Primary | General Well-being as Assessed by SF-36 Questionnaire | Assessment of: physical functioning, social functioning, mental health, pain, change in health, physical role limitation, mental role limitation, energy and vitality, health perception over preceding 4 weeks (other than change in health, which is a comparison to health the preceding year), expressed as a transformed score range 0-100, with a higher score indicating better function/freedom from pain etc | Posted | Mean | Standard Deviation | units on a scale | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
|
|
|
|
| Primary | Short-term Memory Recall | testing of verbal word presentation-immediate recall of 10 words (60 seconds for recall) Maximum =10, minimum =0 | Posted | Mean | Standard Deviation | words | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
|
|
|
|
| Primary | Estimated VO2 Max | VO2 max estimated via submaximal exercise test-submaximal treadmill walking test Calculated via formula: VO2max= 15.1+21.8 x speed (miles per hour) - 0.327 x heart rate (beats per minute) - 0.263 x speed x age (years) + 0.00504 x heart rate x age + 5.98 x gender (0=female, 1=male) | Posted | Mean | Standard Deviation | millilitres/kilogram/minute | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
|
|
|
|
| Primary | Physical Function-"Get up and go" Test | participant will be timed standing up from chair unaided,walking 30m, turning round and returning to a seated position on the chair, the average time of 3 attempts will be recorded. | Posted | Mean | Standard Deviation | seconds | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
|
|
|
|
| Primary | Ankle Brachial Pressure Index (ABPI) | ratio of blood pressure in left arm and right ankle | Posted | Mean | Standard Deviation | ABPI | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
|
|
|
|
| Primary | Long-term Memory Recall | testing of verbal word presentation-delayed recall of 10 words 10 minutes after words initially presented (within 60 seconds). Maximum= 10 words, minimum = no words | Posted | Mean | Standard Deviation | words | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
|
|
|
|
| Primary | Executive Function (Verbal Fluency Test) | written verbal fluency test: participant asked to write down as many English words as possible within 60 seconds, starting with a particular letter of the alphabet, excluding proper nouns or plurals. Baseline assessment-letter A Post Control assessment -letter S After HIT assessment -letter F | Posted | Mean | Standard Deviation | words | Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks |
|
|
|
|
| 1 |
| 12 |
| 0 |
| 12 |
|
Not provided
Not provided
Not provided
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
|
| 0.101 |
| Superiority or Other |
|
| 0.028 |
| Superiority or Other |
|
| Mental Health |
|
| Pain |
|
| Change in Health |
|
| Physical Role Limitation |
|
| Mental Role Limitation |
|
| Energy/Vitality |
|
| Health Perception |
|
| 0.566 |
| Superiority or Other |
| ANOVA | For the analysis of Mental Health | 0.246 | Superiority or Other |
| ANOVA | For the analysis of Pain | 0.145 | Superiority or Other |
| ANOVA | For the analysis of Change in Health | 0.085 | Superiority or Other |
| ANOVA | For the analysis of Physical Role Limitation | 0.114 | Superiority or Other |
| ANOVA | For the analysis of Mental Role Limitation | 0.841 | Superiority or Other |
| ANOVA | For the analysis of Energy/Vitality | 0.366 | Superiority or Other |
| ANOVA | For the analysis of Health Perception | 0.745 | Superiority or Other |